Comvest Partners Enters in Definitive Agreement to Sell Systems Control to Hubbell Incorporated
WEST PALM BEACH, Fla–(BUSINESS WIRE)–#comvestpartners–Comvest Partners (“Comvest”), a middle-market private investment firm, is pleased to... Read more.
Arrowhead Pharmaceuticals to Participate in Jefferies London Healthcare Conference
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in a... Read more.
Market Simplified Launches Nitro XP: Revolutionizing Financial Services in APAC
SINGAPORE–(BUSINESS WIRE)–#FinancialServices—Market Simplified, a leader in advanced enterprise financial solutions, proudly introduces Nitro XP,... Read more.
Ed Freedman’s Stable Road Foundation Renews Long-running Partnership With Imua Family Services
MAUI, Hawaii–(BUSINESS WIRE)–Philanthropist Ed Freedman’s Stable Road Foundation has once again announced its support of Imua Family Services as a... Read more.
Extreme Networks Announces Investor Conference Schedule for November and December 2023
MORRISVILLE, N.C.–(BUSINESS WIRE)–Extreme Networks, Inc. (Nasdaq: EXTR), a leader in cloud networking, today announced its investor conference schedule... Read more.
Advent Technologies Announces Intent with Airbus to Launch a Joint Benchmarking Project
BOSTON–(BUSINESS WIRE)–Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in the fuel cell and hydrogen technology space,... Read more.
Verastem Oncology Announces Efficacy and Safety Data of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in Heavily Pretreated Patient Population
Planned Subgroup Analysis of RAMP 201 Data Showed Combination Demonstrated Robust Efficacy in Recurrent LGSOC Regardless of Number and Class of Prior Therapies Including... Read more.
Orum Therapeutics Announces Acquisition of ORM-6151 Program by Bristol Myers Squibb
BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics (“Orum”), a clinical-stage private biotechnology company pioneering... Read more.
Rand Capital Reports 12% Increase in Total Investment Income for Third Quarter 2023
Total investment income increased 12% to $1.7 million for the quarter compared with the third quarter last year driven by strong growth in interest income Net asset... Read more.
Click Therapeutics Secures $20 Million Debt Financing from HSBC
NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced... Read more.